Generic Name |
||
---|---|---|
IND |
PD-0325901 | |
Brand Name (US) |
||
Manufacturer |
Pfizer | |
Drug Type |
MEK inhibitor | |
Delivery |
Oral | |
Approval Status |
Phase 1 | |
Indications |
||
Overall Strategy |
Oncogenic Signal Path Based | |
Strategy |
Block KIT Signal Path | |
Drug Category |
MEK inhibitor |
Links |
|
Trials of this drug |
|
Trial results |